Jump to content
  • Content Count

  • Joined

  • Last visited

Clive Flashman


Community Reputation

9 Novice


About Clive Flashman

  • Rank

Profile Information

  • First name
  • Last name
  • Country
    United Kingdom

About me

  • About me
    I'm leading on the development of the hub for Patient Safety Learning. I have a background in patient safety, having worked at the National Patient Safety Agency from 2002 to 2007, designing and leading the development of the NRLS. So looking forward to sharing this bold expriment with you all!!
  • Organisation
    Patient Safety Learning
  • Role
    Chief Digital Officer

Recent Profile Visitors

1,203 profile views
  1. Community Post
    I have always believed that as a patient, I should own my data and that healthcare professionals are merely 'stewards' of it. I believe that legally it is owned by the Secretary of State (or at least it used to be). If I want to sell my information, I should be able to, with a highly transparent way of tracking who uses it (Blockchain or Holochain anyone?) There is an interesting company in the USA called Healix (or similar) that takes your genomic data and manages it on your behalf, only allowing other companies access to it on your behalf when you give permission, and you can revoke access at any time. A good model that could be applied more widely .....
  2. News Article
    No single solution will stop the virus’s spread, but combining different layers of public measures and personal actions can make a big difference. It’s im­por­tant to un­der­stand that a vac­cine, on its own, won’t be enough to rapidly ex­tin­guish a pan­demic as per­ni­cious as Covid-19. The pan­demic can­not be stopped through just one in­ter­ven­tion, be­cause even vac­cines are im­per­fect. Once in­tro­duced into the hu­man pop­u­la­tion, viruses con­tinue to cir­cu­late among us for a long time. Fur­ther­more, it’s likely to be as long as a year be­fore a Covid-19 vac­cine is in wide-spread use, given in­evitable dif­fi­cul­ties with man­u­fac­tur­ing, dis­tri­b­u­tion and pub­lic ac­ceptance. Con­trol­ling Covid-19 will take a good deal more than a vac­cine. For at least an­other year, the world will have to rely on a mul­ti­pronged ap­proach, one that goes be­yond sim­plis­tic bro­mides and all-or-noth­ing re­sponses. In­di­vid­u­als, work-places and gov­ern­ments will need to con­sider a di­verse and some­times dis­rup­tive range of in­ter­ven­tions. It helps to think of these in terms of lay­ers of de­fence, with each layer pro­vid­ing a bar­rier that isn’t fully im­per­vi­ous, like slices of Swiss cheese in a stack. The ‘Swiss cheese model’ is a clas­sic way to con­cep­tu­al­ize deal­ing with a haz­ard that in­volves a mix­ture of hu­man, tech­no­log­i­cal and nat­ural el­e­ments. This article can be read in full on the WSJ website, but is paywalled. The illustration showing the swiss cheese pandemic model is hyperlinked to this hub Learn post.
  3. News Article
    Study finds 54 days after discharge, 69% of patients still had fatigue, and 53% were suffering from persistent breathlessness. Almost seven out of 10 patients hospitalised due to coronavirus still suffer from debilitating symptoms more than seven weeks after being discharged, according to a new study. Researchers from the University College London (UCL) division of medicine, in collaboration with with clinicians at the Royal Free London (RFL) and UCL, followed 384 patients who had tested positive and had been treated at Barnet Hospital, the Royal Free Hospital or UCLH. Collectively the average length of stay in hospital was 6.5 days. The team found that 54 days after discharge, 69% of patients were still experiencing fatigue, and 53% were suffering from persistent breathlessness. They also found that 34% still had a cough and 15% reported depression. In addition 38% of chest radiographs (X-rays) remained abnormal and 9% were getting worse. Dr Swapna Mandal, an honorary clinical associate professor at UCL division of medicine, said the data shows so-called long COVID is a real phenomenon and that further research is needed to understand how the symptoms of COVID-19 can be treated over an extended period. She said: "Patients whose COVID-19 illness is serious enough for them to require hospital care often continue to suffer significant symptoms for many weeks after their discharge." Read full story Source: Sky News, 11 November 2020
  4. News Article
    Talking Medicines, a social intelligence company for the pharmaceutical industry, has secured £1.1 million funding deal to scale up its AI-based platform for measuring patient sentiment. Tern, an investment company specialising in the Internet of Things (“IoT”), is the lead investor in a syndicated funding round alongside The Scottish Investment Bank, Scottish Enterprise’s investment arm. Led by CEO Jo Halliday alongside co-founders Dr Elizabeth Fairley and Dr Scott Crae, Talking Medicines will use the funds to support the launch and roll-out of a new AI data platform, which will translate what patients are saying into intelligence by providing a global patient confidence score by medicine. As part of these plans, the business intends to immediately recruit 9 new employees to the NLP data tech team. Formed in 2013 to create new ways of capturing the voice of the patient, the Glasgow-based firm uses a combination of AI, machine learning and Natural Language Processing (NLP) tech tools to capture and analyse the conversations and behaviours of patients at home, with the aim of transforming big pharma’s understanding of patient sentiment. Through mapping the patient voice from social media and connected devices to regulated medicine information, it is able to build data points to determine trends and patterns of patient sentiment across medicines. The round brings the total raised by the firm to £2.5m, including three previous seed funding rounds with previous investors including impact investor SIS Ventures and the Scottish Investment Bank. Talking Medicines CEO Halliday, said: “This investment will scale our team and the development of our AI, ML, NLP tech tools to translate what patients are saying into actionable pharma grade intelligence through our global patient confidence score by medicine.”
  5. Community Post
    I've seen a lot recently on work being done around rarer NCDs, the 'long-tail' of diagnostic go'to's. I know that a company call Volv based in Switzerland has been trying to create an AI system smart enough to bring these into the normal diagnostic process, not sure how successful they have been yet.
  6. News Article
    Researchers at UCL-led collaboration i-sense, have published a dashboard to collate data on five stages, Find, Test, Track, Isolate and Support, with an aim to provide a complete picture of the pandemic. The i-sense COVID Response Evaluation Dashboard (COVID RED) collates and presents data from the Office of National Statistics, Public Health England, and the NHS under five categories; Find, Test, Track, Isolate and Support for those asked to Isolate (FTTIS). It presents indicators of performance under each of these headings, and identifies areas where more data is needed. Co-developer Professor Christina Pagel, UCL Mathematics & Physical Sciences, said: “Increasing volumes of data are being shown in the media and in government press conferences as a basis for local tightening of restrictions.” “However, these data are often from disparate sources, and are not linked together to give a more complete picture of how we are doing. This was the motivation behind our dashboard development. We wish to contribute to the public understanding of COVID-19’s spread, and support policymakers in identifying current areas of the Find, Test, Trace, Isolate and Support structure requiring strengthening.” Read full article Source: Health Tech Newspaper, 30 October 2020 To access the dashboard, click here
  7. Community Post
    "Are there patient safety design standards for software development?" I don't think so specifically around Patient Safety
  8. Content Article
    Health Education England (HEE) has brought together a wide range of relevant resources (including links to other websites) from sources such as UNICEF, Allergy UK, Diabetes UK, Age UK and many others for the benefit of the public. The resources are split as follows: Children & Young People Older people Cancer & Coronavirus Long Term conditions Mental wellbeing Carers, and Looking after yourself There are also resources in accessible formats too. Access the website here
  9. News Article
    Almost half of all staff absence linked to coronavirus in parts of northern England Tens of thousands of NHS staff are off sick or self-isolating because of coronavirus, according to data shared with The Independent as the second wave grows. In some parts of northern England, more than 40% – in some cases almost 50% – of all staff absences are linked to COVID-19, heaping pressure on already stretched hospitals trying to cope with a surge in virus patients. The problem has sparked more calls for wider testing of NHS staff from hospital leaders and nursing unions who warned safety was being put at risk because of short staffing on wards. Across England, more than 76,200 NHS staff were absent from work on Friday – equivalent to more than 6% of the total workforce. This included 25,293 nursing staff and 3,575 doctors. Read full article Source: The Independent, 1 November 2020
  10. Article Comment
    Thanks @Richard Jones I was doing sentiment analysis on Tweets about 5-6 years ago for a client in the USA. It became evident that people were much more willing to make the effort to post a negative review than they were a positive one. This can of course skew the overall conclusions massively. I am reminded of my sadly departed friend, Michael Seres, who when he wasn't getting the support he needed from clinicians here in the UK, published his test results online via Twitter and received advice from clinicians from all over the world. It completely changed the way his condition was managed. There is always this tension between gaining appropriate context about a patient, and the need for privacy - this is something that has to be decided on a case by case basis.
  11. Community Post
    Thanks for the positive endorsement. Of course that leads to the ethics/ governance question...... if an AI makes an incorrect diagnosis, who takes ownership of that mistake? The clinician, the Trust where they work, the developer/ implementer of the AI??? Still lots of questions to be answered, but as you say, HUGE potential for improvement.
  12. Article Comment
    @Richard Jones - what is your take on this?
  13. News Article
    A qualitative study of Twitter hashtags revealed power hierarchies can damage the patient experience and clinician relationship. In an analysis of a popular Twitter hashtag, researchers found that patients largely take umbrage when they feel their doctor does not believe their ailment or knowledge about their healthcare, and when they perceive a power hierarchy between themselves and their clinician. Although not as many patients are using Twitter to get peer feedback on certain providers (the Binary Fountain poll showed only 21% of patients do this), the social media website still holds a lot of power, researchers from the University of California system explained. Twitter is a large platform that hosts social discourse. Healthcare professionals use Twitter to disseminate public health and patient education messages and to network, while 61% of patients use Twitter to learn more about their health, as well. Read full article Source: Patient Engagement HIT, 29 October 2020
  14. News Article
    What does whistleblowing in a pandemic look like? Do employers take concerns more seriously – as we would all hope? Does the victimisation of whistleblowers still happen? Does a pandemic compel more people to speak up? We wanted to know, so Protect analysed the data from all the Covid-19 related calls to theirr Advice Line. They found: * 41% of whistleblowers had Covid-19 concerns ignored by employers * 20% of whistleblowers were dismissed * Managers more likely to be dismissed (32% ) than non-managers (21%) They found that too many whistleblowers feel ignored and isolated once they raise their concerns and that these failing are a systematic problem. Protect, which runs an Advice Line for whistleblowers, and supports more than 3,000 whistleblowers each year, has been inundated with Covid-19 whistleblowing concerns, many of an extremely serious nature. Its report, The Best Warning System: Whistleblowing During Covid-19 examines over 600 Covid-19 calls to its Advice Line between March and September. The majority of cases were over furlough fraud and risk to public safety, such as a lack of social distancing and PPE in the workplace.